AQST logo

Aquestive Therapeutics, Inc. Common Stock

AQST

AQST: Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

more

Show AQST Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of AQST by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AQST's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Oral film compositions and dosage forms having precise active dissolution profiles Jan. 03, 2023
  • Patent Title: Pharmaceutical compositions with enhanced permeation Mar. 15, 2022
  • Patent Title: Process for manufacturing a resulting pharmaceutical film Dec. 28, 2021
  • Patent Title: Enhanced delivery epinephrine compositions Dec. 07, 2021
  • Patent Title: Enhanced delivery epinephrine compositions Nov. 02, 2021
  • Patent Title: Dual lane coating Sep. 28, 2021
  • Patent Title: Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions Aug. 03, 2021
  • Patent Title: Reduction in stress cracking of films Mar. 16, 2021
  • Patent Title: Manufacturing of small film strips Mar. 09, 2021
  • Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Jan. 12, 2021
  • Patent Title: Sublingual and buccal film compositions Nov. 03, 2020
  • Patent Title: Process for manufacturing a resulting pharmaceutical film Aug. 04, 2020
  • Patent Title: Reduction in stress cracking of films Nov. 05, 2019
  • Patent Title: Manufacturing of small film strips Apr. 30, 2019
  • Patent Title: Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom Oct. 30, 2018
  • Patent Title: Sublingual and buccal film compositions Jul. 31, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of AQST in WallStreetBets Daily Discussion

AQST News

Recent insights relating to AQST

CNBC Recommendations

Recent picks made for AQST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AQST

Corporate Flights

Flights by private jets registered to AQST